“To ensure continued medtech and biotech progress, IP strategies must be clever; just like the technology driving such innovations”

With over 10 years’ experience as a medical scientist, Amanda has worked in both diagnostic and research laboratories in the healthcare sector. Her experience relates to DNA analysis, gene rearrangement studies and cell flow cytometry for the diagnosis of cancer and haematological disorders as well as immunohaemotology and diagnostic biochemistry and microbiology. 

Amanda has specific expertise in biotechnology and its application in the healthcare sector. This has created opportunities for Amanda to advise clients on pharmaceutical chemistry, molecular biology and its applications in the medicinal and agricultural fields, food technology and processing, plant breeder’s rights, nutraceuticals, diagnostic methods and vaccine technology. 

In addition to her private sector work, Amanda also works with several public-sector clients. By way of example, Amanda advised the Western Australian State Government on the implementation of the State’s Intellectual Property Policy and providing advice on the protection, management and commercialisation of public sector IP. 

Amanda was recently accepted as a Fulbright Scholar, during which she will spend time at the Leukaemia & Lymphoma Society (LLS) in New York to strengthen the collaboration between Snowdome and LLS.

Qualifications

  • Graduate Diploma in Intellectual Property Law - The University of Melbourne
  • Bachelor of Applied Science (Medical Technology, Haematology) - RMIT University
  • Registered Patent and Trade Mark Attorney (Australia and New Zealand)
  • Company of Directors Course - Foundations of Directorship, Australian Institute of Company Directors